Lurasidone

Overview

Lurasidone is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1237021).

API suppliers (1)

Suppliers of Lurasidone backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• MSN PHARMACHEM PRIVATE LTD2 active DMF

Patent & exclusivity (US)

Per the FDA Orange Book (83 approved US products), the latest listed US patent on Lurasidone expires 23 Nov 2031. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

(1R,2S,6R,7S)-4-[[(1R,2R)-2-[[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]methyl]cyclohexyl]methyl]-4-azatricyclo[5.2.1.02,6]decane-3,5-dione

Canonical SMILES

C1CC[C@H]([C@@H](C1)CN2CCN(CC2)C3=NSC4=CC=CC=C43)CN5C(=O)[C@H]6[C@@H]7CC[C@@H](C7)[C@H]6C5=O

InChIKey

PQXKDMSYBGKCJA-CVTJIBDQSA-N